HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients.

Abstract
Hepatitis E virus (HEV) infections are responsible for chronic hepatitis in immunocompromised patients, and this can evolve to cirrhosis. Like all RNA viruses, HEV exists as a mixture of heterogeneous viruses defining quasispecies. The relationship between the genetic heterogeneity described as a quasispecies, cytokine secretion, and the outcome of acute hepatitis in immunocompromised patients remains to be elucidated. We cloned and sequenced the region encoding the M and P capsid domains of HEV from eight solid-organ transplant (SOT) patients with acute HEV infection who subsequently cleared the virus and from eight SOT patients whose infection became chronic. We analyzed the cytokines and chemokines in the sera of these SOT patients by multianalyte profiling. The nucleotide sequence entropy and genetic distances were greater in patients whose infections became chronic. A lower K(a)/K(s) ratio was associated with the persistence of HEV. The patients who developed chronic infection had lower serum concentrations of interleukin-1 (IL-1) receptor antagonist and soluble IL-2 receptor. Increased concentrations of the chemokines implicated in leukocyte recruitment to the liver were associated with persistent infection. Those patients with chronic HEV infection and progressing liver fibrosis had less quasispecies diversification during the first year than patients without liver fibrosis progression. Great quasispecies heterogeneity, a weak inflammatory response, and high serum concentrations of the chemokines involved in leukocyte recruitment to the liver in the acute phase were associated with persistent HEV infection. Slow quasispecies diversification during the first year was associated with rapidly developing liver fibrosis.
AuthorsSebastien Lhomme, Florence Abravanel, Martine Dubois, Karine Sandres-Saune, Lionel Rostaing, Nassim Kamar, Jacques Izopet
JournalJournal of virology (J Virol) Vol. 86 Issue 18 Pg. 10006-14 (Sep 2012) ISSN: 1098-5514 [Electronic] United States
PMID22761386 (Publication Type: Journal Article)
Chemical References
  • Capsid Proteins
  • Chemokines
  • Cytokines
  • ORF2 protein, Hepatitis E virus
  • RNA, Viral
  • Viral Proteins
Topics
  • Adult
  • Base Sequence
  • Capsid Proteins (genetics)
  • Chemokines (blood)
  • Cytokines (blood)
  • Disease Progression
  • Female
  • Hepatitis E (etiology, immunology, virology)
  • Hepatitis E virus (genetics, pathogenicity)
  • Humans
  • Immunocompromised Host
  • Liver Cirrhosis (etiology, immunology, virology)
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Organ Transplantation (adverse effects)
  • RNA, Viral (genetics)
  • T-Lymphocytes (immunology)
  • Viral Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: